Estimating Cancer Incidence, Prevalence, and the Number of Cancer Patients Treated with Anti-tumor Th erapy in 2015 and 2020 – Analysis of the Czech National Cancer Registry

Abstract

The analysis documents a serious increase in cancer incidence and prevalence in the Czech Republic in years 2015 and 2020 when compared to the situation in 2011. Regarding the estimated numbers of patients requiring active antitumor therapy, the model confirms a continuous increase that must be accounted for in the future planning of health care in the Czech Republic.